Delivering on the promise: two years on from the Life Sciences Vision

Speakers:

• George Freeman MP, Former Minister for Science, Research and Innovation, Department for Science, Innovation and Technology
• Lord O'Shaughnessy, Co-Founder and Senior Partner, Newmarket Strategy
• Dame June Raine DBE, Chief Executive, Medicines and Healthcare Regulatory Agency
• Stuart Carroll, Director, Market Access and Policy Affairs, Moderna

The UK's life sciences industry is at the forefront of a competitive global market, as evidenced by the speed with which we discovered and deployed effective COVID-19 vaccines. From pioneering advancements in genomics and biotech, to revolutionising healthcare delivery systems, the UK's life sciences sector is a powerful tool for innovation and resilience. And, beyond its vital contribution to GDP, it also plays a key role in the nation's health.

The Government has long recognised the importance of this sector, publishing the 'Life Sciences Vision' in July 2021 – a strategy created in partnership industry directly. With four ambitious preconditions for success – making the NHS a better innovation  partner, more investment in science and research, better use of NHS data, and  improved access to capital – it was always likely to require significant spending and concerted focus.

Re:State was delighted to welcome George Freeman MP, former Minister for Science, Research and Innovation in the Department for Science, Innovation and Technology; Lord O'Shaughnessy, Co-Founder and Senior Partner of Newmarket Strategy; Dame June Raine DBE, Chief Executive, Medicines and Healthcare Regulatory Agency; and Stuart Carroll, Director of Market Access and Policy Affairs at Moderna to this panel to discuss the next steps for the Life Sciences Vision.

This event is kindly supported by Moderna.